Eiji Numagami

Title: Eiji Numagami: Innovator in Pharmaceutical Chemistry

Introduction

Eiji Numagami is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 2 patents. His work focuses on the development of compounds that have potential applications in medicine.

Latest Patents

One of Eiji Numagami's latest patents is a preparation method for optically active bicyclic gamma-amino acid compounds. The objective of this invention is to provide an optically active bicyclic γ-amino acid derivative in high purity. This can be achieved through a mixture of specific compounds or a method for producing a compound represented by a particular formula.

Another significant patent involves crystalline forms of thiazolidinedione compounds and their manufacturing methods. This invention aims to provide a crystalline form of a thiazolidinedione compound that is effective as a pharmaceutical ingredient for creating a peroxisome proliferator-activated receptor (PPAR) activator and an anticancer pharmaceutical composition. The invention relates to a crystalline form of a hydrate of a specific thiazolidinedione compound.

Career Highlights

Eiji Numagami is currently associated with Daiichi Sankyo Company, Limited, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Throughout his career, Eiji has collaborated with notable colleagues, including Yoshitaka Nakamura and Kazutoshi Ukai. These collaborations have further enhanced his research and development efforts.

Conclusion

Eiji Numagami is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to advancing medical science and improving therapeutic options.